middle.news
Microba Doubles Core Test Sales, Eyes FY26 Break-Even Amid Strategic Shift
9:26am on Thursday 26th of February, 2026 AEDT
•
Healthcare
Read Story
Microba Doubles Core Test Sales, Eyes FY26 Break-Even Amid Strategic Shift
9:26am on Thursday 26th of February, 2026 AEDT
Key Points
Core test sales up 113% globally to 10,258 in H1 FY26
Microbiome Explorer now 55% of total revenue, up from 20%
Legacy product discontinuation completed, enabling clean revenue growth
Operational efficiencies including AI and lab consolidation to save $1m+
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
MICROBA LIFE SCIENCES (ASX:MAP)
OPEN ARTICLE